Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CFSAN Constituent Updates

CFSAN Constituent Updates Home
          Food
          News & Events from CFSAN
          CFSAN Constituent Updates
          FDA Outlines Strategy to Enhance the Safety of Powdered Infant FormulaCFSAN Constituent Updates FDA Outlines Strategy to Enhance the Safety of Powdered Infant Formula
  
  	
    Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    PrintConstituent Update

November 15, 2022

The U.S. Food and Drug Administration has released an outline of a prevention strategy under development to prevent *Cronobacter sakazakii* illnesses associated with consumption of powdered infant formula.

This prevention strategy is being developed following a large-scale recall of powdered infant formula earlier this year. Powdered infant formula was recalled because FDAinvestigators found insanitary conditions in a manufacturing facility, which possibly contributed to *Cronobacter sakazakii* infections in four infants. The recall added further pressure to an already stressed supply-chain, making it difficult for caregivers of infants to find certain powdered infant formula products earlier this year.  While the supply of infant formula products has been steadily increasing and the FDA continues to work with manufacturers to maximize production and fill store shelves, this strategy will outline our path toward enhancing the safety of these products.

Food safety is a shared responsibility and stakeholder engagement is critical to inform our collective next steps.  The outline released today is intended to guide discussions during further development of FDA’s strategy to prevent *Cronobacter sakazakii* illnesses associated with consumption of powdered infant formula*.*In the coming weeks, teams from across the FDA will be meeting with stakeholders to further discuss, hear their ideas, and finalize the prevention strategy.  Following this engagement, we intend to release an updated summary of the powdered infant formula strategy on FDA.gov, just as we did with those, we recently released for bulb onions and importedenoki and wood ear mushrooms. The updated summary will outline where we are and where we are going in our efforts to enhance the safety of powdered infant formula and will continue to be updated over time as more information is learned.

More information on the strategy can be found on FDA’s Prevention Strategies to Enhance Food Safety webpage and questions or comments can be sent to FoodSafetyPreventionStrategies@fda.hhs.gov.

**For More Information:**

Outline of FDA’s Strategy to Help Prevent Cronobacter sakazakii Illnesses Associated with Consumption of Powdered Infant Formula

                                                                                  Content current as of:
      11/15/2022
              
              
Regulated Product(s)
		 Food & Beverages
			  			     			  						              
			
			
			
			
			
						  Infant Formula & FoodsCFSAN Constituent Updates
 Subscribe to CFSAN Constituent Updates
                        Get email updates delivered to your inbox.
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop